Vivos (RDGL) Total Debt Growth (1y) (2011 - 2021)
Powered by 
Analysis
Vivos (RDGL) Total Debt Growth (1y) (2011 - 2021) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 142.67% |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | -1.59% |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | -9.88% |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 8.95% |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 0.12% |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | -9.07% |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | - |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 12.29% |
| 10 | Vivos | 23.21 Mn | 23.21 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2021 | 0.00% |
| Jun 30, 2021 | 0.00% |
| Mar 31, 2021 | 1,694.07% |
| Dec 31, 2020 | -42.37% |
| Sep 30, 2020 | -19.32% |
| Jun 30, 2020 | 51.54% |
| Mar 31, 2020 | -99.54% |
| Dec 31, 2019 | -85.54% |
| Sep 30, 2019 | -98.90% |
| Jun 30, 2019 | -96.66% |
| Mar 31, 2019 | 3.74% |
| Dec 31, 2018 | -43.91% |
| Sep 30, 2018 | 1,387.22% |
| Jun 30, 2018 | 235.93% |
| Mar 31, 2018 | 151.05% |
| Dec 31, 2017 | 779.98% |
| Sep 30, 2017 | 60.30% |
| Jun 30, 2017 | -0.35% |
| Mar 31, 2017 | -85.74% |
| Dec 31, 2016 | -84.92% |